3'-DEAMINO-3'-(4-MORPHOLINYL)DAUNORUBICIN
UNII LUH3EK22ST

Substance Identification & Data

This profile provides standardized clinical and technical data for 3'-deamino-3'-(4-morpholinyl)daunorubicin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LUH3EK22ST.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 79867-78-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
LUH3EK22ST
CAS Registry Number
79867-78-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
3'-DEAMINO-3'-(4-MORPHOLINYL)DAUNORUBICIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C31H35NO11
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
OYIWRKOSDGPKFD-XGGCRALDSA-N
Line notation for describing the chemical structure and connectivity of atoms.
Substance Type
3?-Deamino-3?-(4-morpholinyl)daunorubicin
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O1CCN([C@@H]2[C@@H]([C@@H](O[C@](C2)(O[C@H]3C[C@@](Cc4c(c5C(c6c(c(ccc6)OC)C(c5c(O)c43)=O)=O)O)(C(C)=O)O)[H])C)O)CC1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 3'-deamino-3'-(4-morpholinyl)daunorubicin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

3′-Deamino-3′-(4-morpholinyl)daunorubicin
CCRIS 5081
Morpholinodaunorubicin

Systematic Nomenclature

(8S,10S)-8-Acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(4-morpholinyl)-α-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione
5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(4-morpholinyl)-α-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)-
5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-(4-morpholinyl)-α-L-lyxo-hexopyranosyl]oxy]-, (8S-cis)-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record